1.Executive Summary
From deindustrialization narrative to state-managed stabilization
The "Mood" Index: January 2026
Cautious repositioning amid historic policy interventions
January 2026 represents a critical juncture for the German chemical industry, defined by a paradoxical mix of structural erosion and the first substantive policy interventions aimed at long-term stabilization. As the industry moves past an "exhausting" 2025, the sentiment is characterized by a "cautious repositioning" rather than a broad-based recovery.
The ifo Business Climate Index improved marginally to -23.5 points from -24.6 in December 2025. This slight uptick masks a deepening crisis in current operations, as the index for the current business situation fell sharply to -34.9 points, down from -29.7. The industry is effectively operating in two speeds: a stagnant, loss-making present and a future being aggressively reshaped by massive state subsidies and corporate restructuring.
The "deindustrialization" narrative has finally met its political counterweight. Three historic milestones—the 5-cent industrial electricity price, the BASF Ludwigshafen site agreement, and the KSpTG carbon storage framework—provide the first structural floor beneath the sector. Yet the VCI forecasts a further 1% production decline and 2.5% sales drop for 2026, confirming that the era of cheap energy and unlimited export growth has been officially replaced by a "High-Tech, High-Efficiency" model supported by state intervention.
Key Indicators at a Glance
ifo Business Climate
-23.5
pts (up from -24.6)
Capacity Utilization
72.7%
vs. 80.9% average
Order Backlogs
+3.4
pts (first positive reading)
VCI 2026 Forecast
-1.0%
production ex. pharma
The Global Decoupling
This domestic contraction stands in sharp contrast to the global projection of +2.9% growth in chemical production, driven by China (+5.0%), India (+3.0%), and South Korea (+3.0%). Germany is not just growing slower; it is shrinking while the rest of the world expands.
Top 3 Headline Events
The 5-Cent Industrial Electricity Price
On January 1, 2026, the German government's multi-billion-euro subsidy program for energy-intensive industries officially commenced. This mechanism caps electricity prices at 5 euro cents/kWh for 50% of a company's consumption, providing a vital bridge for roughly 2,000 firms facing international competition. Companies must reinvest at least 50% of the subsidy into decarbonization or demand-flexibility projects within 48 months.
Strategic Implications
- •Covers approximately 2,000 energy-intensive firms in direct competition globally
- •50% reinvestment requirement ties survival to sustainable transformation
- •Gas storage levy abolition saves industry over €3 billion additionally
BASF Ludwigshafen Site Agreement
Effective January 1, 2026, BASF entered a five-year agreement that guarantees no compulsory redundancies at its flagship site through December 31, 2028. The social peace is traded for €1.5-2.0 billion in annual investment and a commitment to transform Ludwigshafen into Europe's leading sustainable chemical hub. Simultaneously, a €1 billion annual cost-savings program must be delivered by end of 2026.
Strategic Implications
- •Five-year social peace in exchange for technological modernization
- •€1.5–2.0 billion annual investment commitment to Ludwigshafen
- •Q3 2025 net income fell 39.9% YoY, heightening urgency of €1B cost target
KSpTG: Carbon Storage and Transport Act
The recodified legal framework for commercial carbon capture and storage (CCS) and transport became operational in January. This enables the development of a nationwide CO2 pipeline network and offshore storage options. For the "hard-to-abate" chemical segments like ammonia and basic organics, this is transformational enabling technology.
Strategic Implications
- •Legal basis for nationwide CO2 pipeline network modeled on gas regulations
- •Federal states can "opt-in" for onshore storage—southern states actively exploring
- •Coal-fired operators excluded from CO2 network to prioritize industrial transitions
Strategic Conclusions
Capital Allocation
- →Defensive regarding Germany (Standort D)
- →Offensive regarding US and China expansion
- →Transformation overshadowed by rationalization
Political Reality
- →Grid fee subsidies 2026: band-aid, not solution
- →Gap between Green Deal and industrial reality never wider
- →Structural guarantees for CapEx decisions absent
2.Macroeconomic & Regulatory Landscape
State-Managed Stability and Energy Cost Breakthrough
The macroeconomic environment in January 2026 is marked by a divergence between falling producer prices and stubbornly high operational costs. While the broader German economy is projected to grow by 1.1% in 2026—ending six years of stagnation—the chemical sector continues to lag, with the VCI forecasting a 1% decline in production and a 2.5% drop in sales revenue for the year. The energy landscape has entered a phase of state-managed stability.
The 5-Cent Revolution: Energy Cost Breakthrough
Energy Price Movements (Dec 2025 vs Dec 2024)
Distribution costs falling
5-cent cap now active
Lower naphtha costs
€6.5B subsidy applied
5-Cent Industrial Electricity Price
For 50% of consumption
Energy-intensive industries
Into decarb within 48 months
Effective Jan 1, 2026
REACH & Microplastics Reporting
2026 marks the opening of the first reporting window for microplastic emissions under EU REACH. Manufacturers of synthetic polymer microparticles must now track and report emissions.
- • "One Substance, One Assessment" (OSOA) in force since Jan 1
- • CLP Revision: new hazard classes for endocrine disruptors
- • Mixtures must comply with new CLP by May 1, 2026
Streamlines ECHA/EFSA assessments but adds compliance burden for specialty firms.
€3B Cleantech State Aid
The EU approved a €3 billion German state aid scheme for cleantech manufacturing, aligned with the Clean Industrial Deal. Funding targets batteries, solar panels, and electrolyzers—core growth markets for specialty chemicals.
- • Supports domestic production of strategic net-zero technologies
- • Hydrogen Acceleration Act designates H2 as "overriding public interest"
- • €200M Germany-Canada hydrogen deal approved by EC
Largest state-supported cleantech push in German industrial history.
VCI Forecast: 2025 Review & 2026 Outlook
| Category | 2025 Performance | 2026 Forecast | Key Drivers |
|---|---|---|---|
| Chemical Production (ex. Pharma) | -2.5% | -1.0% | Structural plant closures and low domestic demand |
| Pharmaceuticals Production | +3.0% | +2.0% | Resilient demand for innovative therapies |
| Total Sales Revenue | -1.0% | -2.0% | Lower producer prices and volume contraction |
| Export Volume | -3.0% | -3.5% | US tariffs and Chinese overcapacity |
| Employment | -0.5% | -1.0% (est.) | Restructuring at BASF, Evonik, and Wacker |
VCI "Six-Point Proposal": Further bureaucracy reduction (ifo estimates €146 billion annual cost to the economy), modernization of the debt brake to prioritize industrial investment, and long-term energy cost certainty beyond the 5-cent mechanism.
Producer Prices
-2.5%
December 2025 vs. December 2024 (Destatis)
Deflationary pressure persists across chemical segments
GDP Growth 2026
+1.1%
Goldman Sachs forecast for Germany
Ending six years of stagnation; +0.5pp fiscal boost
2026 Outlook: Three Critical Risks
US Trade Policy & Tariffs
NegativeThe narrowing trade surplus with the US (down 9.4% in 2025) and persistent threat of tariffs remain a primary concern. Export-oriented chemical leaders face margin compression as 'local-for-local' production accelerates.
Impact: Accelerated CAPEX diversion from Germany to US; chemical exports under sustained pressure.
Chinese Overcapacity: 'China Shock 2.0'
NegativeState-controlled firms continue building capacity regardless of demand, flooding European markets. Basic chemicals, polymers, and polyamides are most exposed. DOMO Chemicals' insolvency is a direct casualty.
Impact: Permanent plant closures in German basic chemicals; only specialty niches defensible.
Execution Risk on Restructuring
MixedThe success of BASF's €1B cost program, Wacker's 'PACE' (€300M), and Evonik's 'Tailor Made' (€400M) is not guaranteed. Any failure to hit savings targets could trigger further credit downgrades.
Impact: Maturities for CCC/C issuers spike in 2028-2029; execution deadlines are tight.
The 'Chemistry 4.0' Thesis
PositiveThe massive fiscal commitments from Berlin and Brussels, paired with stabilization of domestic orders (+3.4 pts), suggest the industry has found its footing. Not a return to the past, but the birth of a leaner, more sustainable sector.
Impact: Winners: Pharma, specialty chemicals, AI materials. Losers: Basic inorganics, standard polymers.
"The era of cheap energy and unlimited export growth has officially been replaced by a 'High-Tech, High-Efficiency' model supported by state intervention. The recovery of 2026 will not be a return to the past, but the birth of a leaner, more sustainable, and more resilient 'Chemistry 4.0.'"
3.Corporate Movers & Shakers
'Standort D' Modernization Meets Aggressive International Capex
The "Big Players" of the DAX and MDAX are responding to the stagnant domestic environment with a combination of "Standort D" modernization and aggressive international capex shifting. January 2026 brought landmark site agreements, dramatic impairments, and a clear bifurcation between companies that have found their restructuring footing and those still searching for a floor.
BASF SE: The Ludwigshafen Social Contract
BASF SE
BAS.DEFive-Year Site Agreement Secures Social Peace
- •January 1: New site agreement effective—no compulsory redundancies until Dec 31, 2028
- •Investment commitment: €1.5–2.0 billion annually in Ludwigshafen modernization
- •Focus: Europe’s leading sustainable chemical hub, not capacity expansion
- •€1 billion annual cost-savings program must be delivered by end of 2026
- •Q3 2025 net income fell 39.9% YoY to €172 million
Outlook: Defensive crouch turned strategic pivot. Social peace exchanged for technological modernization and AI-driven productivity.
The "Transformation and Flexibility" Accord
Digital Transformation
Agreement explicitly targets "continuous productivity gains" through AI, smart maintenance, and autonomous logistics across the Verbund site.
Financial Pressure
Deutsche Bank forecasts just 3% EBITDA growth for 2026. Warburg upgraded to Buy with target raised to \u20AC53, betting on restructuring momentum.
Bayer AG: The Life Science Pivot
At the J.P. Morgan Healthcare Conference on January 13, Bayer unveiled a pipeline-heavy strategy aimed at offsetting litigation risks in Crop Science.
ASUNDEXIAN
26% reduction in stroke risk in late-stage trials
SIRIUS STUDY
Phase II initiated for targeted thrombolysis
BofA TARGET
Price target raised to \u20AC55; turning point narrative
Wacker Chemie: The €800M Wake-Up Call
Wacker Chemie AG
WCH.DENet Loss of €800M vs. €261M Profit in 2024
- •January 28: Preliminary 2025 results released—€800M net loss
- •€310M write-down of Siltronic AG stake
- •€195M deferred tax assets in Germany no longer recoverable
- •'PACE' program targets €300M annual cost savings
- •Silicones division sales -3% to €2.73B; Polysilicon -7% to €885M
Outlook: Semiconductor-grade polysilicon remains a bright spot. Solar and standard silicones under sustained pressure from Chinese overcapacity.
Anatomy of the €800M Loss
Evonik & Lanxess: Restructuring for the Cycle
Evonik Industries AG
EVK.DE'Tailor Made' on Track: 2,000 Jobs, €400M Savings
- •2,000 jobs to be eliminated by end-2026 (1,500 in Germany)
- •Targeting €400M in annual savings from 'Tailor Made' restructuring
- •Goldman Sachs upgraded to Buy in January—cited lean structure
- •Americas designated as growth engine under Elias Lacerda
Outlook: Hollowing out of German HQ functions. Pro-cyclical positioning favored by Goldman as a leveraged recovery play.
Lanxess AG
LXS.DEPrice Increases Signal Firming Markets
- •January 26: Announced price increases for adipic acid
- •Goldman raised to Neutral—valuation at two-decade low vs. EBITDA
- •Rebounding from historic price lows as a leveraged cycle bet
- •Specialty intermediates showing early signs of demand firming
Outlook: Most levered play on European chemical cycle turn. High risk, high potential reward as demand normalizes.
Resilient Performers: Henkel & Merck
Henkel AG
HEN3.DEATP Adhesive Systems Acquisition
- •January 16: Acquired ATP Adhesive Systems
- •Expanding from liquid adhesives into high-performance specialty tapes
- •Targeting fast-growing industrial water-based adhesive markets
- •Consumer business providing stable cash flow to fund bolt-ons
Outlook: Adhesive Technologies portfolio deepening. Consumer hedge plus industrial expansion = balanced model.
Merck KGaA
MRK.DESemiconductor Materials & New Electronics CEO
- •Taiwan semiconductor solutions site inaugurated (Dec 2025)
- •Benjamin Hein appointed CEO Electronics effective May 2026
- •High-performance computer in Munich accelerating materials R&D
- •Different cycle: pharma + semiconductor = secular growth drivers
Outlook: High-tech chemical investment center of gravity shifting to East Asia. AI materials demand providing structural tailwind.
Strategic Divergence: January 2026
Expanding / Pivoting
- Bayer: Pipeline rally, €38 to €44.80
- Merck: Taiwan site + AI materials
- Henkel: ATP acquisition, adhesives growth
Restructuring / Stabilizing
- BASF: Site agreement + €1B cost program
- Evonik: 2,000 jobs, Goldman upgrade to Buy
- Lanxess: Cycle bet, adipic acid pricing power
Under Pressure
- Wacker: €800M net loss, PACE needed
- German Mittelstand: 20% considering relocation
- Basic chemicals: China overcapacity + closures
4.Innovation & Transformation
From Risk to Infrastructure
January 2026 marks the moment Germany's green-industrial strategy shifts from theoretical ambition to operational infrastructure. The Hydrogen Acceleration Act, the Carbon Dioxide Storage and Transport Act (KSpTG), and unprecedented funding commitments are turning policy papers into construction sites. The innovation bifurcation identified in previous editions is resolving: projects with regulatory backing and subsidy certainty are now scaling, while the distinction between "proceeding" and "stalling" increasingly maps onto "state-backed" versus "market-only."
Green Hydrogen and Carbon Management
Germany Leads European Hydrogen Build-Out
With 993 MW of hydrogen capacity under construction—representing 35% of the entire European total—Germany has moved from ambition to execution. The Hydrogen Acceleration Act designates hydrogen facilities as "overriding public interest," fast-tracking permitting and clearing legal obstacles that stalled previous projects.
Hydrogen Infrastructure Build-Out
Germany has committed massive public funding and legal acceleration to hydrogen, closing the gap between targets and construction.
- •993 MW under construction, 35% of European hydrogen capacity pipeline
- •Hydrogen Acceleration Act grants 'overriding public interest' status to hydrogen facilities
- •€6 billion ($7 billion) earmarked for 2026 hydrogen and CCS projects
- •'CO2 Contracts for Difference' de-risk investment by offsetting cost disparity for 15 years
Verdict: The subsidy architecture is now operational. Construction pace must match funding ambition.
EU-Backed International Hydrogen
The EU has approved a landmark cross-Atlantic hydrogen deal, validating Germany's global sourcing strategy.
- •EU approved €200 million Germany-Canada hydrogen deal
- •Innovative 'double auction' system matches producers and buyers transparently
- •First operational cross-Atlantic green hydrogen supply chain for industrial use
- •Model for future bilateral hydrogen corridors with Australia and North Africa
Verdict: International sourcing strategy now has EU-level endorsement and a working transaction model.
The KSpTG and Industrial CCS
Carbon Dioxide Storage and Transport Act — Active January 2026
The KSpTG is now in force, creating the legal basis for a nationwide CO2 pipeline network. For energy-intensive chemical clusters in the Ruhr and Rhine regions, this is a game-changer: unavoidable process emissions from ammonia, ethylene oxide, and cement-adjacent chemistry can finally be captured and transported to permanent storage rather than vented to the atmosphere.
CO2 Infrastructure Framework
The KSpTG establishes a comprehensive legal framework for industrial carbon capture, transport, and storage in Germany.
- •Legal basis now exists for constructing a nationwide CO2 pipeline network
- •Federal states can 'opt-in' for onshore CO2 storage, allowing regional flexibility
- •Coal-fired power plants are explicitly excluded from the CO2 network
- •Focus on unavoidable industrial process emissions aligns with chemical sector needs
Verdict: The legal framework is in place. Pipeline planning and construction timelines are next.
Impact on Chemical Clusters
Ruhr and Rhine energy-intensive clusters stand to gain the most from the new CO2 infrastructure provisions.
- •Ammonia, ethylene oxide, and soda ash producers can plan for long-term CCS integration
- •Proximity to North Sea storage sites creates natural CO2 transport corridors
- •Combined with CO2 Contracts for Difference, 15-year cost certainty for abatement investments
- •VCI has called the KSpTG 'the most significant decarbonization enabler of the decade'
Verdict: A genuine game-changer for chemical decarbonization. Implementation speed is now the key variable.
Digitalization and "Lab of the Future"
Merck HPC for Materials Science
Merck launched a high-performance computer in Munich dedicated to accelerating materials science and drug discovery. The system combines AI-driven molecular simulation with experimental data to compress development cycles from years to months.
This investment signals that Germany's specialty chemicals leaders are betting on computational chemistry as a competitive moat—where deep science and engineering culture compound rather than erode.
BASF Ludwigshafen AI Agreement
BASF's Ludwigshafen Verbund site agreement targets "continuous productivity gains" through AI, covering smart maintenance, autonomous logistics, and process optimization across the integrated production network.
The digitalization push is defensive as much as offensive: smart maintenance and autonomous logistics reduce operating costs at a site where labor and energy costs are already under severe pressure.
Regulatory Innovation
2026: The Year of Regulatory Convergence
Multiple regulatory packages take effect simultaneously in early 2026, creating both compliance burdens and innovation opportunities. The chemical industry faces new reporting obligations, revised hazard classifications, and streamlined assessment processes—all at once.
REACH and CLP Updates
New REACH reporting obligations and CLP hazard classes create significant compliance complexity for the chemical sector.
- •First reporting window for microplastic emissions opens in 2026 under REACH
- •CLP revision introduces new hazard classes for endocrine disruptors
- •Companies must reclassify and relabel affected product portfolios
- •Compliance costs concentrated in SMEs without dedicated regulatory teams
Verdict: Manageable for large players, but the cumulative burden on mid-market firms is substantial.
OSOA and State Aid
The One Substance One Assessment (OSOA) package and cleantech state aid approvals modernize the regulatory landscape.
- •OSOA in force January 1, 2026: streamlines ECHA/EFSA assessment processes
- •Eliminates duplicative evaluations across different EU regulatory bodies
- •€3 billion EU cleantech manufacturing state aid approved specifically for Germany
- •State aid enables subsidies for battery, solar, and green chemistry manufacturing at scale
Verdict: OSOA is a genuine efficiency gain. Cleantech state aid provides critical investment certainty.
The Innovation Bifurcation: January 2026 Status
The bifurcation identified in late 2025 is resolving into a clear pattern: state-backed projects with legal certainty are scaling rapidly, while market-only ventures without subsidy frameworks continue to stall. The gap between the two tracks is widening.
Scaling
- →Hydrogen build-out (993 MW under construction, Acceleration Act in force)
- →Industrial CCS under KSpTG (CO2 pipeline network legally enabled)
- →CO2 Contracts for Difference (15-year cost certainty for abatement)
- →AI-driven process optimization (Merck HPC, BASF Ludwigshafen digitalization)
- →International hydrogen sourcing (EU-approved Germany-Canada corridor)
- →Cleantech manufacturing (€3 billion EU state aid for Germany)
Stalling
- →Market-only green hydrogen without subsidy or offtake guarantees
- →Biomass-to-chemicals at scale (economics still unfavorable)
- →SME regulatory compliance (REACH microplastics, CLP endocrine disruptors)
- →Onshore CO2 storage (dependent on federal state opt-in decisions)
- →CapEx-intensive green projects without 15-year contract certainty
5.Financial Radar
From Value Trap to Pro-Cyclical Bet
January 2026 marks a notable inflection point: for the first time in years, sell-side analysts are cautiously turning bullish on European chemicals. Goldman Sachs has shifted to a "pro-cyclical" stance, Warburg Research upgraded BASF to Buy, and Bayer staged the most dramatic rally in the sector. The narrative is shifting from "value trap" to "pro-cyclical bet" — though the macro backdrop remains fragile and execution risks are high.
Economic Indicators
German GDP Growth
1.1%
Goldman forecast for 2026
Fiscal Deficit
3.7%
Widening; supports industrial subsidies
Sector Upside (GS)
13-18%
18% for diversified players
10Y Bund Yield
3.25%
Forecast by end 2026
Macro Backdrop: Early Signs of Stabilization
Goldman forecasts 1.1% GDP growth for Germany in 2026, supported by a fiscal boost of 0.5 percentage points from defense and infrastructure spending. The fiscal deficit is widening to 3.7%, which paradoxically supports industrial subsidies and energy cost relief.
On the credit side, S&P expects speculative-grade default rates to fall to 3.25%, easing refinancing pressure on leveraged names like Lanxess. Meanwhile, 17 million tonnes of European chemical capacity have been permanently closed since 2022, suggesting the supply-side adjustment is finally catching up to demand.
January 2026 Stock Performance
Star performer. Rallied sharply from €38 at the start of January, driven by pipeline optimism and improving litigation sentiment. BofA raised target to €55.
Stabilized by Ludwigshafen site agreement and multiple Buy ratings. Warburg upgraded from Hold to Buy with target raised from €43 to €53. Dividend yield remains a key anchor.
Boosted by Goldman upgrade to Buy and dividend focus. Recovery from 2025 lows as construction cycle sentiment improves.
Rebounding from historic lows. Goldman raised to Neutral, citing pro-cyclical positioning. Viewed as a leveraged bet on the cycle turning.
Impacted by €800M net loss disclosure, but PACE restructuring program provides a medium-term anchor. Solar exposure remains an overhang.
Strong 2025 results offset by caution on 2026 demand outlook. Consumer resilience vs. industrial softness creates a balanced picture.
Analyst Sentiment: The Pro-Cyclical Pivot
After years of downgrades and capitulation, January 2026 saw a meaningful shift in sell-side positioning. Goldman Sachs led the charge with a sector-wide reassessment.
Pro-Cyclical Pivot on European Chemicals
- -Shifted to 'pro-cyclical' view of European chemicals sector
- -Upgraded Evonik and Symrise to Buy, raised Lanxess to Neutral
- -Sees average 13% upside across coverage, 18% for diversified players
- -Forecasts 1.1% German GDP growth supported by fiscal expansion
BASF Upgraded to Buy
- -Upgraded BASF from Hold to Buy
- -Price target raised from €43 to €53
- -Cites Ludwigshafen site agreement and restructuring progress
- -Sees dividend yield as defensible floor for the stock
Top Cyclical Picks: BASF and Bayer
- -Bullish on BASF and Bayer as best-positioned cyclical plays
- -Favors names with self-help stories and restructuring momentum
- -Sees European chemicals as undervalued relative to US peers
Bayer Target Raised to €55
- -Raised Bayer price target to €55, reflecting pipeline confidence
- -Improving litigation outlook reduces tail risk discount
- -Sees potential for re-rating as pharma pipeline matures
Consensus View: Cautious Bullishness
The sell-side narrative has shifted from "value trap" to "pro-cyclical bet." For the first time in years, multiple bulge-bracket banks are simultaneously upgrading European chemical names. Goldman sees 13-18% upside, capacity closures are tightening supply, and fiscal expansion is providing a demand floor.
However, this remains cautious bullishness, not outright conviction. Energy costs are still structurally higher than in the US or Middle East, China overcapacity persists, and the 17 million tonnes of closed capacity reflect permanent industrial loss, not temporary adjustment. The bull case hinges on cyclical mean-reversion, not structural improvement.
Investment Thesis Summary
Pro-Cyclical Favorites
- -Bayer: Pipeline rally + BofA target at 55 Euro
- -BASF: Warburg upgrade + 5%+ dividend yield
- -Evonik: Goldman Buy + dividend focus
Watch List
- -Lanxess: Leveraged cycle bet, rebounding
- -Henkel: Defensive anchor, limited upside
Caution
- -Wacker: 800M Euro net loss, solar overhang
- -Energy costs still 2-3x US levels
- -China overcapacity unresolved
The sector is transitioning from value trap to pro-cyclical bet. Goldman's pivot, 17 million tonnes of closed capacity, and fiscal expansion are creating the first constructive setup in years — but it remains a trade, not a trend, until energy costs and demand fundamentals structurally improve.